Korean biotech firm names first Chief Sustainability Officer
Cha is tasked with strengthening CHA Biotech's ESG management system.
Korean cell and gene therapy firm CHA Biotech has appointed Cha Won-Tae as its first Chief Sustainability Officer.
CHA Biotech is a part of the CHA Bio Group, a healthcare conglomerate founded in 1960. CHA Biotech itself was established in 2002 and conducts genetic and stem cell research to find advanced treatment for rare or incurable diseases.